Christopher R. Christensen Ensign Group, Inc (ENSG) insider trading activity

Christopher R. Christensen is Executive Chairman of ENSIGN GROUP, INC. Currently has a direct ownership of 12,539 shares of ENSG, which is worth approximately $1.69 Million. The most recent transaction as insider was on Sep 10, 2024, when has been sold 13,721 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K

0% 3M change

19.45% 12M change

Total Value Held $1.69 Million

Christopher R. Christensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2024	SELL Bona fide gift	-	13,721 Reduced 52.25%	12,539 Common Stock
May 30 2024	SELL Payment of exercise price or tax liability	$74,648 $118.49 p/Share	630 Reduced 2.34%	26,260 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$68,503 $118.93 p/Share	576 Reduced 2.1%	26,890 Common Stock
May 20 2024	SELL Payment of exercise price or tax liability	$26,422 $119.56 p/Share	221 Reduced 0.8%	27,466 Common Stock
Apr 24 2024	BUY Acquisition or disposition by will or laws	-	7,219 Added 20.68%	27,687 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	$576,259 $117.58 p/Share	4,901 Added 19.32%	20,468 Common Stock
Oct 27 2023	SELL Bona fide gift	-	46,965 Reduced 75.11%	15,567 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$351,515 $88.61 p/Share	3,967 Reduced 5.97%	62,532 Common Stock
May 30 2023	SELL Payment of exercise price or tax liability	$109,270 $88.05 p/Share	1,241 Reduced 1.83%	66,499 Common Stock
May 26 2023	SELL Payment of exercise price or tax liability	$24,622 $88.57 p/Share	278 Reduced 0.41%	67,740 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	-	2,800 Added 3.95%	68,018 Common Stock
Feb 07 2023	BUY Grant, award, or other acquisition	$595,502 $89.86 p/Share	6,627 Added 9.22%	65,218 Common Stock
May 31 2022	SELL Payment of exercise price or tax liability	$402,603 $81.17 p/Share	4,960 Reduced 7.8%	58,591 Common Stock
May 27 2022	SELL Payment of exercise price or tax liability	$20,438 $82.41 p/Share	248 Reduced 0.39%	63,551 Common Stock
May 26 2022	BUY Grant, award, or other acquisition	-	2,800 Added 4.2%	63,799 Common Stock
Apr 04 2022	SELL Open market or private sale	$10,929,554 $89.95 p/Share	121,507 Reduced 66.58%	60,999 Common Stock
Apr 04 2022	BUY Exercise of conversion of derivative security	$1,944,112 $16.0 p/Share	121,507 Added 61.78%	75,157 Common Stock
Feb 08 2022	BUY Grant, award, or other acquisition	$535,092 $73.17 p/Share	7,313 Added 10.71%	60,999 Common Stock
Aug 31 2021	SELL Payment of exercise price or tax liability	$16,252 $81.67 p/Share	199 Reduced 0.37%	53,686 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$399,543 $83.92 p/Share	4,761 Reduced 8.12%	53,885 Common Stock
May 28 2021	SELL Payment of exercise price or tax liability	$16,557 $83.2 p/Share	199 Reduced 0.34%	58,646 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	2,500 Added 1.41%	174,688 Common Stock
Feb 19 2021	BUY Grant, award, or other acquisition	$393,108 $83.64 p/Share	4,700 Added 2.66%	172,188 Common Stock

Also insider at

PNTG

Pennant Group, Inc. Healthcare

Director

CRC